Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial

• Main Authors: Chun-li Lu (Author), Liu-qing Yang (Author), Xin-yan Jin (Author), Thomas Friedemann (Author), Yu-fei Li (Author), Xue-han Liu (Author), Xiao-ying Chen (Author), Xiang-yun Zou (Author), Bing-rui Zhang (Author), Fu-xiang Wang (Author), Yuan-long Lin (Author), Yi-min Tang (Author), Meng-li Cao (Author), Ya-lin Jiang (Author), You-fang Gao (Author), Kui Liu (Author), Zhen-gang Tao (Author), Nicola Robinson (Author), Sven Schröder (Author), Jian-ping Liu (Author), Hong-zhou Lu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The COVID-19 pandemic has had a profound global impact, although the majority of recently infected cases have presented with mild to moderate symptoms. Previous clinical studies have demonstrated that Shufeng Jiedu (SFJD) capsule, a Chinese herbal patent medicine, effectively alleviates...